| Emily Jacox, MD | |
|
2626 Capital Medical Blvd, Tallahassee, FL 32308-4402 | |
| (850) 325-5000 | |
| Not Available |
| Full Name | Emily Jacox |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 2626 Capital Medical Blvd, Tallahassee, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265176069 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | TRN37334 (Florida) | Primary |
| 207N00000X | Dermatology | 37334 (Florida) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily Jacox, MD 2626 Capital Medical Blvd, Tallahassee, FL 32308-4402 Ph: () - | Emily Jacox, MD 2626 Capital Medical Blvd, Tallahassee, FL 32308-4402 Ph: (850) 325-5000 |
News Archive
Since February 2015, aflibercept (trade name Eylea) has been available also for patients with impaired vision due to macular oedema that follows blockage of branch veins of the central retinal vein (branch retinal vein occlusion, BRVO).
At the inauguration of Hadassah's new day care center of the Sidney Weisner Department of Bone Marrow Transplantation and Cancer Immunotherapy today, Prof. Shimon Slavin, head of the department, described an innovative treatment for cancer patients who have previously undergone chemotherapy, surgery and/ or radiotherapy.
Mesenchymal stem cells (MSCs) are multipotent in that they naturally replenish the cell types that build our bone, cartilage and adipose tissues.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technologies, announced today that the first patients have been enrolled in the INNOVATION trial, which will assess the safety of a new stent graft system, called INCRAFT™, to treat abdominal aortic aneurysm (AAA). An estimated 27 million people worldwide have abdominal aortic aneurysms.
The U.S. Food and Drug Administration today approved Amitiza (lubiprostone) for the treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in adult women aged 18 and over.
› Verified 7 days ago
David Pascoe, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1981 Capital Cir Ne, Tallahassee, FL 32308 Phone: 850-402-9444 Fax: 850-402-0188 | |
Dr. Armand B Cognetta Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1707 Riggins Rd, Tallahassee, FL 32308 Phone: 850-877-4134 Fax: 850-402-9130 | |
Dr. William Harris Green, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1707 Riggins Rd, Tallahassee, FL 32308 Phone: 850-877-4134 Fax: 850-402-9130 | |
Pamela Schofield Kennedy, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1355 Thomaswood Dr, Tallahassee, FL 32308 Phone: 850-656-4555 Fax: 850-656-4557 | |
Dr. Oen-hiang Cynthia Tie, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1981 Capital Cir Ne, Tallahassee, FL 32308 Phone: 850-402-9444 Fax: 850-402-0188 | |
Michael Jay Bernhardt, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1626 Riggins Rd, Tallahassee, FL 32308 Phone: 850-877-4134 Fax: 850-402-9130 |